Lintbells Limited won a Queen's Award for Innovation for developing a nutritional supplement that addresses joint pain in dogs, YUMOVE. YUMOVE was designed to address the joint cycle needs of ageing, sport and working dogs. Previous joint support product contained only glucosamine, Lintbells Limited adapted the supplement to contain Omega 3 fatty acids and hyaluronic acid. The market that the company identified was a mid-price point but with a higher specification than the veterinary products on the market. The efficacy of the product is supported by clinical studies conducted in collaboration with the Royal Veterinary College. The company started trading in 2006 and with the launch of YUMOVE it has grown from five to 38 staff.